Skip to main content

Table 1 Summary of miRNA expression signatures as prognostic parameters

From: Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms

MicroRNAs

Disease progression high → low

Clinical outcome

MiRNA property (Initial analysis)

MiRNA property (Meta-analysis)

Prognosis

High → low

miR-3681

CR/R/C

A/D/C

Oncogene

Oncogene

Inferior

miR-601

CR/R/C

A/D/C

Oncogene

Tumor-suppressor gene

Favorable

miR-320e

R/CR/C

D/A/C

Oncogene

Tumor-suppressor gene

Favorable

miR-34a

R/CR/C

N/A

Oncogene

Oncogene

Inferior

miR-642a

CR/R/C

A/D/C

Oncogene

Tumor-suppressor gene

Favorable

miR-720

C/CR/R

C/A/D

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-891a

C/R/CR

C/D/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-522

C/R/CR

N/A

Tumor-suppressor gene

Oncogene

Inferior

miR-518c

C/CR/R

N/A

Tumor-suppressor gene

Oncogene

Inferior

miR-3665

C/CR/R

N/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-3620

C/CR/R

N/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-382

C/CR/R

N/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-452

C/CR/R

N/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-136

R/CR/C

A/D/C

Oncogene

Oncogene

Inferior

miR-26b

CR/R/C

A/D/C

Oncogene

Oncogene

Inferior

miR-122

C/CR/R

N/A

Tumor-suppressor gene

Tumor-suppressor gene

Favorable

miR-147

C/CR/R

N/A

Tumor-suppressor gene

Oncogene

Inferior

miR-192

R/CR/C

N/A

Oncogene

Oncogene

Inferior

  1. High → Low expression, CR; clinical remission, R; relapse, C; control, A; alive, D; deceased, P; positive, N/A; not applicable.